申请人:IDORSIA PHARMACEUTICALS LTD.
公开号:US20210122736A1
公开(公告)日:2021-04-29
The present invention relates to derivatives of formula (I)
wherein Ring A, W, X, Y, Z, R
1
, R
2
, R
3
and R
4
are as described in the description, to their preparation, to pharmaceutically acceptable salts thereof, and to their use as pharmaceuticals, to pharmaceutical compositions containing one or more compounds of formula (I), and especially to their use as C5a receptor modulators.